Ann: Appendix 3B - ESOP, page-140

I think investors need to get over themselves and realise that healthcare and biotech isn't something you achieve in overnight. This is people's lives in the company's hands. If they wanna make sure there's no kinks and rollout strategically to make sure as many lives are as safe and better off as possible, while adhering to the complex laws of the intensely different countries they are entering/attempting to enter, while looking at funding/acquisition options to strengthen the company, and keeping the product pipeline strong and flowing, knowing their reputations are on the line with a company that can make a genuine difference (unlike RAD or whatever else) and an investor gets upset they don't get updates every time something minor happens or released to their liking all I can really say is get over yourself. The amount achieved in the past 18 months is staggering and if anyone here is upset by how much they get paid- go do it better since you clearly know the ins and outs of how to keep shareholders happy and how all that matters in running a company that has aspirations for being valued in the billions is keeping shareholders super updated on minor issues and cuddling them every time their sad or unsure (about a smallllllll cap biotech?). Maybe the American sector of biotech is a different world because Americans aren't such pussies and don't feel like just because they've thrown money into a company that their entitled to anything. Unless you have an ownership amount Your entitled to the difference between whatever you sell and bought for is. That's it. Don't like it, honestly jog on it's not for you